~~<i id='DB2D678286'><strike id='DB2D678286'><tt id='DB2D678286'><pre id='DB2D678286'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

knowledge

author：entertainment 2025-09-27 23:12:11 - browse：681

Martin Shkreli Securities Fraud Trial — Kevin Hagen/Getty Images

Is this the end of the line for the “pharma bro” with the perpetual smirk?

Martin Skhreli was found guilty on Friday of three counts of fraud after a five-week trial in federal court in Brooklyn, N.Y. He faces a prison sentence that could stretch years.

“This was a witch hunt of epic proportions,” Shkreli said outside court after the verdict, the Washington Post reported. “They may have found some broomsticks.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Weight loss drugs aren’t covered by Obamacare. That may change

leisure time

hotspot

leisure time

explore

entertainment

hotspot

MollyFergusonforSTATSTATnowpublishesselectedLetterstotheEditorreceivedinresponsetoFirstOpinionessays

WSS

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Having children helps parents live longer, especially after age 80

Having children helps parents live longer, especially after age 80

ACIP vaccine advisory panel sees its vacancies filled

ACIP vaccine advisory panel sees its vacancies filled

Wikipedia

knowledge

leisure time

Affirmative action in medical school literally saved lives

Congress considering partial increase for doctor pay in Medicare

Hepatitis C has a cure — but many Americans still lack access to it

Measles policy set amid Florida outbreak alarms vaccine proponents

The cancer drug shortage isn’t new — and neither are the solutions

Eli Lilly reports tirzepatide MASH success during Q4 earnings

Cancer drug shortages should be causing more outrage

FDA warns medical device makers about rise in fabricated data

Psychedelics group wrestles with new pharma identity

Abbott's new heart device gets FDA advisory panel nod

hotspot

Artificial intelligence use in health care faces greater scrutiny in 2024

Weight loss drugs aren’t covered by Obamacare. That may change

Latigo launches with $135 million for Vertex

A new drug could help frostbite victims avoid its ravages

New study raises questions about niacin and heart health

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

leisure time

explore

entertainment

hotspot